Back

Initial experience with the Varipulse pulsed-field ablation system: procedural performance and clinical outcomes at one-year follow-up.

14 April 2026 (08:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Poster session (3): mechanisms and management of arrhythmias Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Eugenia Mateu Gisbert

University Hospital Insular of Gran Canaria, Las Palmas de Gran Canaria (Spain)

188 More presentations in this session

Presentation thumbnail
Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects
Doctor J. Uutela (Jyvaskyla, FI)
Abstract
Presentation thumbnail
A wearable SCG-based approach for early, low-cost screening of valvular heart disease
Doctor V. Pergola (Naples, IT)
Presentation thumbnail
Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study
Doctor B. Hrymniak (Wroclaw, PL)
Abstract
Presentation thumbnail
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Doctor Y. Shhab (Bucharest, RO)
Abstract
Presentation thumbnail
Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort
Ms A. Bondoc (Timisoara, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Procedural outcomes and safety of pulse field ablation using the circular multielectrode array catheter (Pulse Select Catheter) in atrial fibrillation: A real-world prospective study
thumbnail
Congress Presentation
Real-life results of pulmonary vein isolation with the PulseSelect system. Experience of a single tertiary center.
thumbnail
Congress Presentation
Direct comparison of two commercially available pulsed field ablation systems for atrial fibrillation; procedure characteristics and acute outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources